newsfilter
← Latest News
GlobeNewswire·

DiagnaMed Offering its Brain Health AI Platform for Investigating Weight Loss Drugs, such as Semaglutide (GLP-1), on Brain Function

TORONTO, Aug. 15, 2024 (GLOBE NEWSWIRE) -- DiagnaMed Holdings Corp. ("DiagnaMed" or the "Company") (CSE:DMED) (OTCQB:DGNMF), a healthcare technology company focused on brain health using AI, is offering its novel BRAIN